Leritrelvir shows high efficacy against SARS-CoV-2 protease mutations

Coronavirus

Higher Education Press Nov 6 2024 Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible Omicron variant. Omicron has been particularly concerning due to its ability to evade immune protection from vaccines and monoclonal antibodies developed against earlier strains. A critical player in the virus's life cycle is the main protease (M pro ), also known as NSP5 or 3CL

Tag-uri: Coronavirus

Leritrelvir shows high efficacy against SARS-CoV-2 protease mutations https://www.news-medical.net - 06.11.2024 07:43

din zilele anterioare

Leritrelvir shows high efficacy against SARS-CoV-2 protease mutations https://www.news-medical.net - 06.11.2024 07:43